These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 30111763

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Quercetin inhibits angiogenesis mediated human prostate tumor growth by targeting VEGFR- 2 regulated AKT/mTOR/P70S6K signaling pathways.
    Pratheeshkumar P, Budhraja A, Son YO, Wang X, Zhang Z, Ding S, Wang L, Hitron A, Lee JC, Xu M, Chen G, Luo J, Shi X.
    PLoS One; 2012; 7(10):e47516. PubMed ID: 23094058
    [Abstract] [Full Text] [Related]

  • 3. Luteolin inhibits human prostate tumor growth by suppressing vascular endothelial growth factor receptor 2-mediated angiogenesis.
    Pratheeshkumar P, Son YO, Budhraja A, Wang X, Ding S, Wang L, Hitron A, Lee JC, Kim D, Divya SP, Chen G, Zhang Z, Luo J, Shi X.
    PLoS One; 2012; 7(12):e52279. PubMed ID: 23300633
    [Abstract] [Full Text] [Related]

  • 4. Cryptotanshinone inhibits VEGF-induced angiogenesis by targeting the VEGFR2 signaling pathway.
    Xu X, Wu L, Zhou X, Zhou N, Zhuang Q, Yang J, Dai J, Wang H, Chen S, Mao W.
    Microvasc Res; 2017 May; 111():25-31. PubMed ID: 28040437
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Formononetin, a novel FGFR2 inhibitor, potently inhibits angiogenesis and tumor growth in preclinical models.
    Wu XY, Xu H, Wu ZF, Chen C, Liu JY, Wu GN, Yao XQ, Liu FK, Li G, Shen L.
    Oncotarget; 2015 Dec 29; 6(42):44563-78. PubMed ID: 26575424
    [Abstract] [Full Text] [Related]

  • 7. α-santalol inhibits the angiogenesis and growth of human prostate tumor growth by targeting vascular endothelial growth factor receptor 2-mediated AKT/mTOR/P70S6K signaling pathway.
    Saraswati S, Kumar S, Alhaider AA.
    Mol Cancer; 2013 Nov 22; 12():147. PubMed ID: 24261856
    [Abstract] [Full Text] [Related]

  • 8. Sulfated fucoidan FP08S2 inhibits lung cancer cell growth in vivo by disrupting angiogenesis via targeting VEGFR2/VEGF and blocking VEGFR2/Erk/VEGF signaling.
    Chen H, Cong Q, Du Z, Liao W, Zhang L, Yao Y, Ding K.
    Cancer Lett; 2016 Nov 01; 382(1):44-52. PubMed ID: 27569654
    [Abstract] [Full Text] [Related]

  • 9. OSU-A9 inhibits angiogenesis in human umbilical vein endothelial cells via disrupting Akt-NF-κB and MAPK signaling pathways.
    Omar HA, Arafa el-SA, Salama SA, Arab HH, Wu CH, Weng JR.
    Toxicol Appl Pharmacol; 2013 Nov 01; 272(3):616-24. PubMed ID: 23921148
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Tylophorine, a phenanthraindolizidine alkaloid isolated from Tylophora indica exerts antiangiogenic and antitumor activity by targeting vascular endothelial growth factor receptor 2-mediated angiogenesis.
    Saraswati S, Kanaujia PK, Kumar S, Kumar R, Alhaider AA.
    Mol Cancer; 2013 Jul 29; 12():82. PubMed ID: 23895055
    [Abstract] [Full Text] [Related]

  • 13. 6"-Debromohamacanthin A, a bis (indole) alkaloid, inhibits angiogenesis by targeting the VEGFR2-mediated PI3K/AKT/mTOR signaling pathways.
    Kim GD, Cheong OJ, Bae SY, Shin J, Lee SK.
    Mar Drugs; 2013 Apr 02; 11(4):1087-103. PubMed ID: 23549281
    [Abstract] [Full Text] [Related]

  • 14. TKI-31 inhibits angiogenesis by combined suppression signaling pathway of VEGFR2 and PDGFRbeta.
    Zhong L, Guo XN, Zhang XH, Sun QM, Tong LJ, Wu ZX, Luo XM, Jiang HL, Nan FJ, Zhang XW, Lin LP, Ding J.
    Cancer Biol Ther; 2006 Mar 02; 5(3):323-30. PubMed ID: 16575201
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Dioscin inhibits colon tumor growth and tumor angiogenesis through regulating VEGFR2 and AKT/MAPK signaling pathways.
    Tong Q, Qing Y, Wu Y, Hu X, Jiang L, Wu X.
    Toxicol Appl Pharmacol; 2014 Dec 01; 281(2):166-73. PubMed ID: 25111127
    [Abstract] [Full Text] [Related]

  • 18. Platycodin D inhibits tumor growth by antiangiogenic activity via blocking VEGFR2-mediated signaling pathway.
    Luan X, Gao YG, Guan YY, Xu JR, Lu Q, Zhao M, Liu YR, Liu HJ, Fang C, Chen HZ.
    Toxicol Appl Pharmacol; 2014 Nov 15; 281(1):118-24. PubMed ID: 25250884
    [Abstract] [Full Text] [Related]

  • 19. Trans-3,4,5,4'-tetramethoxystilbene, a resveratrol analog, potently inhibits angiogenesis in vitro and in vivo.
    Chen LK, Qiang PF, Xu QP, Zhao YH, Dai F, Zhang L.
    Acta Pharmacol Sin; 2013 Sep 15; 34(9):1174-82. PubMed ID: 23770989
    [Abstract] [Full Text] [Related]

  • 20. Oleanolic Acid Inhibits Colorectal Cancer Angiogenesis by Blocking the VEGFR2 Signaling Pathway.
    Niu G, Sun L, Pei Y, Wang D.
    Anticancer Agents Med Chem; 2018 Sep 15; 18(4):583-590. PubMed ID: 29065844
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.